DPP4 and tuberculosis: The decreased regulation of Th1 cell homing to the lung of TB patients could backfire as an inflammatory overdrive potentially increase inflammation, tissue destruction, and risk of cavernous TB (37); however, the DPP4 class of drugs are considered safe (41) and meta-analysis of post marketing data have not suggested an increased risk (42).